Clik here to view.
Clik here to view.
ノボキュア社オプチューン（NovoTTF-100Aシステム）の日本市場への導入につきまして下記の通りご案内申し上げます。
ジャージー セント・へリア （ビジネスワイヤ）–...
View ArticleClik here to view.
Novocure Announces Commercial Launch of Optune (the NovoTTF-100A System) in...
ST. HELIER, Jersey Novocure, a commercial stage oncology company, announced today that 31 neurosurgeons at medical centers across Japan are trained and certified to prescribe Optune. These...
View ArticleClik here to view.
Mazor Robotics’ Renaissance System Highlighted in Special Session at the...
CAESAREA, Israel Mazor Robotics (TASE:MZOR; NASDAQ GM:MZOR), a developer of innovative guidance systems and complementary products, announced that Dr. Isador Lieberman, a leading orthopaedic spine...
View ArticleClik here to view.
Hanmi Pharmaceutical to Present Its New Targeted Lung Cancer Drug ‘HM61713′...
SEOUL, South Korea Hanmi Pharmaceutical co., Ltd. (KSE:128940) will present the results of the phase I/II domestic clinical trial of HM61713 in patients with EGFR mutation positive non-small cell...
View ArticleClik here to view.
Provectus Biopharmaceuticals’ Abstract on Liver Cancer Accepted for Poster...
KNOXVILLE, Tenn. Provectus Biopharmaceuticals, Inc. (NYSE MKT: PVCT, http://www.pvct.com), a clinical-stage oncology and dermatology biopharmaceutical company (“Provectus” or the “Company”),...
View ArticleClik here to view.
Quintiles Officially Opens Greater China Regional Headquarters in Shanghai
SHANGHAI More than 30 leaders from China’s government and healthcare communities joined Quintiles executives here today in officially opening the Quintiles Greater China Regional Headquarters,...
View ArticleClik here to view.
CORRECTING and REPLACING Quintiles Officially Opens Greater China Regional...
SHANGHAI Third paragraph of release dated May 29, 2015 should read: Vice District Mayor Wang Hongzhou of Xuhui District, Shanghai, joined Dr. Gillings in speaking at the opening. (Instead of Vice...
View ArticleClik here to view.
昆泰正式于上海开设大中华区总部
上海 今天，30余名中国政府官员和医疗保健业内领袖与昆泰高管一同出席了昆泰大中华区地区总部的官方开业仪式，进一步扩大其帮助中国公司在全球范围内进行扩张，以及帮助跨国公司在全球第二大生物制药市场成功开展业务的能力。17年前，昆泰于上海开设首家办事处。 昆泰创始人兼执行董事长Dennis Gillings,...
View ArticleClik here to view.
FDA Approves ViMove for Expanded Use in the United States
MELBOURNE, Australia Medical device company dorsaVi Ltd (ASX:DVL) has received 510(k) clearance by the US Food and Drug Administration expanding the use of ViMove in the United States. The expanded...
View ArticleClik here to view.
Sysmex and LabCorp Announce a Strategic Collaboration for Blood-Based...
KOBE, Japan & BURLINGTON, N.C. Sysmex Corporation (TSE:6869) and Laboratory Corporation of America® Holdings (LabCorp®) (LH:NYSE) today announced a strategic collaboration focused on the...
View ArticleClik here to view.
Cytox Signs Research Agreement with AIBL and Partner Organisations
OXFORD, England Cytox Ltd, an innovative developer of assays for risk assessment and prediction of dementia, has entered into a collaborative research arrangement with leading Australian...
View ArticleClik here to view.
BioCision to Develop Customized ThawSTAR Automated Cell Thawing System for...
SAN RAFAEL, Calif. BioCision, LLC, a leader in advanced technology to improve biological sample handling and standardization, today announced that it will collaborate with Celgene Cellular...
View ArticleClik here to view.
Clik here to view.
Hanmi Pharmaceutical ‘HM61713’ Demonstrated the Effect of Tumor Volume Reduction
SEOUL, South Korea Hanmi Pharmaceutical Co., Ltd. (KSE:128940) presented the interim results of phase I/II domestic clinical trial on HM61713 at the 51st American Society of Clinical Oncology (ASCO)...
View ArticleClik here to view.
European Commission Approves PBT2 Orphan Designation for Huntington’s Disease
MELBOURNE, Australia Prana Biotechnology Limited (ASX:PBT/NASDAQ:PRAN) has today announced that the European Commission has approved orphan designation for PBT2 for the treatment of Huntington’s...
View ArticleClik here to view.
EYE TECH CARE Launches Its Operations in China as Part of Its International...
RILLIEUX-LA-PAPE, France EYE TECH CARE SA (ETC), a company developing and marketing equipment for non-invasive medical treatment in ophthalmology, today announced the launch of the approval process...
View ArticleClik here to view.
Astellas and Anokion to Collaborate on Immune Tolerance Therapeutics – Kanyos...
TOKYO & LAUSANNE, Switzerland Astellas Pharma Inc. (“Astellas”; TSE 4503, headquarters: Tokyo; President and CEO Yoshihiko Hatanaka) and Anokion SA (“Anokion“, headquarters: Lausanne; Chairman...
View ArticleClik here to view.
EYE TECH CARE Launches Its Operations in China as Part of Its International...
RILLIEUX-LA-PAPE, France EYE TECH CARE SA (ETC), a company developing and marketing equipment for non-invasive medical treatment in ophthalmology, today announced the launch of the approval process...
View ArticleClik here to view.
Evaluate Ltd and AdverseEvents, Inc. Team Up to Create New Insight on FDA...
LONDON & BOSTON & TOKYO Life science market intelligence firm, Evaluate Ltd, has partnered with AdverseEvents, Inc. (AEI), a leading healthcare informatics company focused on drug safety...
View Article